ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Miralem Pasic
Matthias Loebe
Yuguo Weng
Roland Hetzer
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pasic, M.
Right arrow Articles by Hetzer, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pasic, M.
Right arrow Articles by Hetzer, R.

Ann Thorac Surg 1996;62:1685-1690
© 1996 The Society of Thoracic Surgeons

Original Articles: Cardiovascular

Heart Transplantation: A Single-Center Experience

Miralem Pasic, MD, PhD, Matthias Loebe, MD, Manfred Hummel, MD, PhD, Onen Grauhan, MD, Josef Hofmeister, MD, Yuguo Weng, MD, Roland Hetzer, MD, PhD

Klinik für Herz-, Thorax- und Gefäßchirurgie, Deutsches Herzzentrum Berlin, Berlin, Germany

Background. The success of heart transplantation led to the extension of the criteria for both recipients and donors. The aim of the study was to evaluate the experience with this therapeutic approach for end-stage heart failure at a single center.

Methods. Between April 1986 and January 1996, 1,413 patients were accepted as candidates for heart transplantation. Ventricular assist devices were used as a bridge to transplantation in 173 patients (biventricular assist device in 141 patients and left ventricular assist device in 32 patients). The longest duration of support was 572 days (average, 46 days).

Results. Of the 1,413 patients, 891 underwent heart transplantation (65 children/adolescents and 826 adults; 522 (36%) patients died awaiting a donor heart. The average time spent on the waiting list was 107 days. The average recipient age was 44 years, and the age of donors was extended up to 69 years. Eighty-three patients with ventricular assist devices (48%) subsequently underwent heart transplantation. Twenty-five patients (2.7%) underwent retransplantation. The 30-day mortality rate was 14%, and the overall actual survival at 1, 5, and 10 years was 80%, 59%, and 50%, respectively. Ninty-four percent of patients were in New York Heart Association functional class I or II at 1 year, and 44% returned to work after transplantation.

Conclusions. Despite the broadening of the selection criteria for both recipients and donors, heart transplantation remains an effective treatment for end-stage heart failure. Nevertheless, this therapeutic approach is severely limited by a considerable disparity between the need and availability of donor organs.




This article has been cited by other articles:


Home page
 CirculationHome page
F. D. Wagner, B. Jonitz, E. V. Potapov, N. Qedra, K. Wegscheider, K. Abraham, E. A. Ivanitskaia, M. Loebe, and R. Hetzer
Procalcitonin, A Donor-Specific Predictor of Early Graft Failure-Related Mortality After Heart Transplantation
Circulation, September 18, 2001; 104 (2009): I-192 - I-196.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
E. A. Bocchi and A. Fiorelli
The paradox of survival results after heart transplantation for cardiomyopathy caused by Trypanosoma cruzi
Ann. Thorac. Surg., June 1, 2001; 71(6): 1833 - 1838.
[Abstract] [Full Text] [PDF]

Home page
 RadioGraphicsHome page
F. D. Knollmann, M. Hummel, R. Hetzer, and R. Felix
CT of Heart Transplant Recipients: Spectrum of Disease
RadioGraphics, November 1, 2000; 20(6): 1637 - 1648.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
F. D. Knollmann, W. Bocksch, S. Spiegelsberger, R. Hetzer, R. Felix, and M. Hummel
Electron-Beam Computed Tomography in the Assessment of Coronary Artery Disease After Heart Transplantation
Circulation, May 2, 2000; 101(17): 2078 - 2082.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
A. C. Yankah, M. Musci, Y. Weng, M. Loebe, H. R. Zurbruegg, H. Siniawski, J. Mueller, and R. Hetzer
Tricuspid valve dysfunction and surgery after orthotopic cardiac transplantation
Eur. J. Cardiothorac. Surg., April 1, 2000; 17(4): 343 - 348.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
M. Pasic, P. Bergs, E. Hennig, M. Loebe, Y. Weng, and R. Hetzer
Simplified technique for implantation of a left ventricular assist system after previous cardiac operations
Ann. Thorac. Surg., February 1, 1999; 67(2): 562 - 564.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
R. Hetzer, E. V. Potapov, J. Muller, M. Loebe, M. Hummel, Y. Weng, H. Warnecke, and P. E. Lange
Daily noninvasive rejection monitoring improves long-term survival in pediatric heart transplantation
Ann. Thorac. Surg., October 1, 1998; 66(4): 1343 - 1349.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
R. Hetzer, W. Albert, M. Hummel, M. Pasic, M. Loebe, H. Warnecke, A. Haverich, and H. G. Borst
Status of Patients Presently Living 9 to 13 Years After Orthotopic Heart Transplantation
Ann. Thorac. Surg., December 1, 1997; 64(6): 1661 - 1668.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1996 by The Society of Thoracic Surgeons.